Gummatous (Soft) Syphilis

• Gummas: painless, granulomatous nodules that may ulcerate; commonly found on skin, bones, liver, and mucous membranes.
• Bone pain or deformities: lesions in the skull, tibia, or long bones can cause localized pain or swelling.
• Skin manifestations: irregular plaques that may be raised, ulcerated, or have a “rubbery” consistency.

Neurosyphilis

• Meningovascular syphilis: headaches, stroke‑like symptoms, or cranial nerve palsies.
• General paresis: progressive mental decline, personality changes, memory loss, and mood disturbances.
• Tabes dorsalis: loss of coordination, lightning‑like pains, urinary incontinence, and a positive Romberg sign.

Cardiovascular Syphilis

• Aortic aneurysm: especially of the ascending aorta; may present as chest or back pain.
• Aortic insufficiency: shortness of breath, fatigue, palpitations.
• Coronary artery ostial narrowing: can lead to angina or myocardial infarction.

Other Systemic Findings

• Interstitial keratitis (eye inflammation) leading to visual disturbances.
• Hepatosplenomegaly (enlarged liver and spleen).
• Joint pain (arthralgia) without obvious inflammation.

Because symptoms develop slowly, many patients attribute them to aging or other chronic illnesses, underscoring the importance of a thorough sexual history and appropriate testing.

Causes and Risk Factors

Quaternary syphilis is caused by the same spirochete that produces primary and secondary disease: Treponema pallidum*subsp.* pallidum. The bacteria enter the body through mucous membranes or compromised skin during sexual contact, blood transfusion (rare with modern screening), or from mother to fetus.

Key Risk Factors

• Unprotected sexual activity: especially anal or vaginal intercourse without condoms.
• Multiple sexual partners: increases exposure probability.
• Men who have sex with men (MSM): higher prevalence in many regions.
• Co‑infection with HIV: HIV impairs immune response, accelerating progression to late disease.
• Poor access to healthcare: delays testing and treatment.
• Pregnancy: untreated maternal syphilis can lead to congenital infection, which may later manifest as late syphilis in the child.

Diagnosis

Diagnosis of late syphilis relies on a combination of serologic testing, clinical assessment, and, when indicated, imaging or biopsy.

Serologic Tests

1. Nontreponemal tests: VDRL (Venereal Disease Research Laboratory) or RPR (Rapid Plasma Reagin). These detect antibodies to cardiolipin; titers are useful for monitoring treatment response.
2. Treponemal tests: FTA‑ABS (Fluorescent Treponemal Antibody‑Absorption), TP‑PA (Treponema pallidum particle agglutination), or enzyme immunoassays (EIAs). Positive treponemal tests remain lifelong even after successful treatment.

In late syphilis, nontreponemal titers are often low (≤1:8) but may still be detectable. A “reverse sequence screening” algorithm (treponemal test first, followed by nontreponemal) is commonly used in U.S. labs.^{[2] CDC, 2024}

Additional Diagnostic Tools

• Lumbar puncture: CSF VDRL, protein, and cell count for suspected neurosyphilis.
• Imaging: MRI or CT for cerebral lesions, stroke, or spinal cord involvement; CT angiography for aortic aneurysm.
• Bone scan or X‑ray: to locate gummatous bone lesions.
• Biopsy: histopathology of a gumma shows granulomatous inflammation with plasma cells; special stains (Warthin‑Starry) may reveal spirochetes.

Treatment Options

Penicillin G remains the gold‑standard therapy for all stages of syphilis, including quaternary disease. Alternative regimens are reserved for penicillin‑allergic patients.

First‑Line Regimen

• Intravenous aqueous crystalline penicillin G: 18–24 million units per day, administered as 3–4 million units every 4 hours for 10‑14 days. This regimen is recommended for neurosyphilis and for patients with cardiovascular involvement.^{[3] WHO, 2023}

Alternative Regimens (if penicillin cannot be used)

• Doxycycline: 100 mg orally twice daily for 28 days (gummatous disease) or 28‑30 days for neurosyphilis (though efficacy is less certain).
• Ceftriaxone: 2 g IV or IM daily for 10‑14 days; considered when penicillin desensitization is not feasible.
• Penicillin desensitization: strongly preferred for neurosyphilis and cardiovascular disease; performed in a monitored setting.

Adjunctive Management

• Analgesics for bone or neuropathic pain (e.g., acetaminophen, NSAIDs, gabapentin).
• Cardiovascular surgery or endovascular repair for large aortic aneurysms.
• Physical therapy and occupational therapy for gait disturbances in tabes dorsalis.
• Psychiatric support for cognitive or mood changes associated with general paresis.

Follow‑up

Patients should have quantitative nontreponemal titers measured at 3, 6, 12, and 24 months after therapy. A four‑fold decline (e.g., from 1:32 to 1:8) is considered an adequate response. Persistent low‑titer positivity may reflect serofast status rather than active infection.^{[4] Mayo Clinic, 2022}

Living with Quaternary Syphilis (Late Syphilis)

While late syphilis can be curable, some organ damage may be irreversible. The following strategies can help patients maintain health and quality of life.

Medical Self‑Management

• Keep a copy of all test results and treatment records; share them with any new healthcare provider.
• Adhere strictly to follow‑up serology schedule; report any rise in titers to your clinician promptly.
• Take prescribed antibiotics exactly as directed; do not stop early, even if you feel better.
• Monitor for new neurologic or cardiac symptoms (e.g., sudden headache, chest pain, vision changes) and seek evaluation without delay.

Lifestyle Adjustments

• Safe sex practices: consistent condom use, regular STI screening for you and your partners.
• Vaccinations: keep up‑to‑date on hepatitis B, HPV, and influenza to reduce co‑infection risk.
• Nutrition & exercise: a balanced diet and regular activity support immune function and cardiovascular health.
• Alcohol & smoking: limit alcohol intake and quit smoking to reduce cardiovascular strain.

Psychosocial Support

• Consider counseling or support groups for coping with chronic disease stigma.
• Inform sexual partners so they can be screened and treated; partner notification can prevent reinfection.
• Access community resources for low‑cost medication or travel assistance to specialty clinics.

Prevention

Prevention of both initial infection and progression to late disease is achievable with public health measures and personal responsibility.

• Routine screening: sexually active adults, especially MSM, pregnant women, and people with HIV, should be screened at least annually.
• Condom use: latex or polyurethane condoms reduce transmission risk by >80 % when used consistently.
• Pre‑exposure prophylaxis (PrEP) programs: while PrEP is for HIV, integrated STI testing is often part of these services.
• Prompt treatment of primary/secondary syphilis: a single dose of benzathine penicillin G (2.4 million units IM) usually prevents late complications.
• Partner notification: use health‑department services or confidential online tools to alert recent partners.
• Maternal screening: all pregnant women should be screened at the first prenatal visit; untreated maternal syphilis can cause congenital disease that later appears as late syphilis in the child.

Complications

If left untreated, quaternary syphilis can cause irreversible damage and life‑threatening events.

• Aortic aneurysm & dissection: risk of catastrophic rupture.
• Severe stroke or intracerebral hemorrhage: from meningovascular syphilis.
• Dementia and psychiatric illness: general paresis may mimic Alzheimer’s disease.
• Blindness: due to interstitial keratitis or optic nerve involvement.
• Gummatous bone destruction: leading to fractures or chronic pain.
• Congenital transmission: infants born to untreated mothers may develop late syphilis as adolescents or adults.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Syphilis – CDC Fact Sheet. 2024. https://www.cdc.gov/std/syphilis/stdfact-syphilis.htm
2. CDC. Laboratory Testing for Syphilis. 2024. https://www.cdc.gov/std/treatment-guidelines/syphilis-lab.htm
3. World Health Organization. WHO Guidelines for the Treatment of Treponemal Infections. 2023. https://www.who.int/publications/i/item/WHO-RHR-23.42
4. Mayo Clinic. Syphilis testing: What the results mean. 2022. https://www.mayoclinic.org/tests-procedures/syphilis-test/about/pac-20394484